▶주메뉴 바로가기
▶본문 바로가기
An affiliate of South Korean biopharmaceutical firm Celltrion said Wednesday that the market share of its biosimilar Herzuma reached 10 percent in Europe during the fourth quarter of last year. Celltrion Healthcare, which handles Celltrion’s overseas business, said Herzuma’s market share reac...
Korean health care startup Sky Labs aims to launch its Cardio Tracker, or CART, a ring-type wearable device that detects a patient’s heart rhythm 24/7 using internet of things technologies. “From the beginning, our goal was to penetrate Europe and the US. We will also launch the product in South...
SK Biopharmaceuticals, the new drug development unit of South Korea’s telecom-to-energy conglomerate SK Group , is gearing up to go public on the main bourse Kospi. According to industry sources, the company recently sought proposals from seven major Korean securities firms to pick a deal manag...
GC Pharma announced on April 4 that it has signed a deal with Clinigen KK in Japan to license out its Hunter syndrome treatment Hunterase ICV. Hunter syndrome is a rare genetic disorder that interferes with the patient’s ability to break down and recycle certain complex sugars. Its symptoms inclu...
Kolon Life Science announced on April 1 that it has decided to suspend sales of its new osteoarthritis drug Invossa. According to the company, the decision was made after the its US unit Kolon TissueGene found going through the advanced and recently developed examination method STR that a compon...
South Korea’s bio sector is gaining both attention and traction, with many claiming their successful global expansion. While not all of them can deliver on their word, Daewoong Pharmaceutical is one of the few companies here that is expecting to benefit from its past investments. The company is ...
Celltrion ’s founder and Chairman Seo Jung-jin announced on March 26 that the company aims to begin selling its biosimilar Truxima in the US within the second half of this year. Seo -- who is in Tokyo on business -- made the announcement over the phone during Celltrion’s 28th shareholders meeti...
National Pension Service has decided to oppose key proposals by Samsung Biologics ahead of the company’s scheduled shareholders meeting on March 22. The key proposals include approval of the financial statement and appointment of inside and outside executives. After having a meeting on March 20,...
SK Biopharmaceuticals, the new drug development unit of South Korea’s telecom-to-energy conglomerate SK Group, announced on March 21 that it has received marketing approval from the US Food and Drug Administration for its narcolepsy drug Sunosi based on solriamfetol, a compound it discovered. Sun...
South Korea’s biotherapeutics firm SillaJen announced on March 20 that it has decided to secure additional funds worth 110 billion won ($97.31 million) through issuing convertible bonds. The company said that the funds will mainly be used for developing its drug candidate Pexa-Vec, an oncolytic...
Korean pharmaceutical companies have high hopes of leaping forward this year by boosting research and development to develop new drugs. According to a survey conducted by the Korea Pharmaceutical and Bio-Pharma Manufacturers Association, over 100 Korean pharma firms possess a total of 953 self-dev...
South Korean drug maker Donga Pharmaceutical said on March 18 that it will roll out its diabetes drug Suganon in India next month. India-based pharmaceutical firm Alkem Laboratories won exclusive rights to distribute and market the treatment medicine for type 2 diabetes. It will be officially a...
Several South Korean pharmaceutical companies have decided to make new facility investments in a bid to hone their competitiveness, industry sources said on March 18. The decisions, made at annual shareholder meetings, are seen as reflecting their efforts to streamline and expand infrastructure...
Prosecutors raided South Korea’s main stock exchange on March 15 as part of a probe into alleged accounting fraud by Samsung BioLogics. Investigators from the Seoul Central District Prosecutors’ Office were sent to search the Korea Exchange in western Seoul. They also raided the offices o...
South Korean internet giant Naver said on March 15 that it has established a joint venture with Daewoong Pharmaceutical to provide medical data analysis services based on its artificial intelligence technology. Seoul National University Budang Hospital will also be working with the new JV as a...
Korean builders nervous about possible setbacks in Middle East
HD Hyundai chair receives honorary doctorate from HUFS
SC Bank Korea offers special interest rate for new members
Hyundai-Kia marks 40 years of partnerships with over 100 suppliers: report
Samsung expected to introduce new Exynos processor in next Galaxy series
Woori, KB ink QR code payment partnership with Cambodia